Effect of low-dose prednisone (with calcium and calcitriol supplementation) on calcium and bone metabolism in healthy volunteers

British Journal of Rheumatology

Volumn 37, Issue 1, 1998, Pages 27-33

  Lems, W F ^a   Van Veen, G J M ^b   Gerrits, M I ^a   Jacobs, J W G ^a   Houben, H H M L ^b   Van Rijn, H J M ^a   Bijlsma, J W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

Author keywords

Corticosteroids; Low dose prednisone; Osteocalcin; Osteoporosis; Pyridinolines

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; HYDROXYPROLINE; OSTEOCALCIN; PARATHYROID HORMONE; PREDNISONE; PROCOLLAGEN; PYRIDINOLINE; SODIUM;

ADULT; ARTICLE; BONE METABOLISM; CALCIUM EXCRETION; CALCIUM INTAKE; CALCIUM METABOLISM; HUMAN; HUMAN EXPERIMENT; MALE; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; SODIUM INTAKE; URINARY EXCRETION;

EID: 0031822173     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/37.1.27     Document Type: Article

References (49)

1. Dyckman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1985;28:361-8.
2. Ruegsegger P, Medici TC, Anliker M. Corticosteroid-induced bone loss. A longitudinal study in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 1983;25:615-20.
3. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983;309:265-8.
4. Lems WF, Jahangier ZN, Jacobs JWG, Bijlsma JWJ. Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroids. Clin Exp Rheumatol 1995;13:293-7.
5. Lems WF, Jacobs JWG, van den Brink HR, van Rijn HJM, Bijlsma JWJ. Transient decrease in osteocalcin and markers of collagen type 1 formation during corticosteroid pulse therapy. Br J Rheumatol 1993;32:787-90.
6. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990;112:352-64.
7. Adachi JD, Bensen WJ, Hodsman AB. Corticosteroid-induced osteoporosis. Semin Arthritis Rheum 1993;22:375-84.
8. Sambrook PN, Jones G. Corticosteroid osteoporosis. Br J Rheumatol 1995;34:8-12.
9. Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH. Altered mineral metabolism in glucorticoid-induced osteopenia. J Clin Invest 1979;64:655-65.
10. Klein RG, Arnaud SB, Gallagher JC, DeLuca HF, Riggs BL. Intestinal calcium absorption in exogenous hypercortisonism. J Clin Invest 1977;60:253-9.
11. Suzuki Y, Ichikawa Y, Saito E, Homma M. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 1983;32:151-6.
12. Sambrook PN, Cohen ML, Eisman JA, Pocock NA, Champion GD, Yeates MG. Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 1989;48:535-8.
13. Leboff MS, Wade JP, Maclowiak S, Fuleihan GEH, Zangari M, Liang MH. Low dose prednisone does not affect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis. J Rheumatol 1991;18:339-44.
14. Garton MJ, Reid DM. Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis. Arthritis Rheum 1993;36:222-7.
15. Hall GM, Spector TD, Griffin AJ, Jawad ASM, Hall ML, Doyle DV. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum 1993;36:1510-6.
16. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM. Effects of low dose corticosteroids on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol 1995;22:1055-9.
17. Bijlsma JWJ. Bone metabolism in patients with rheumatoid arthritis. Clin Rheumatol 1988;7:16-23.
18. Laan RFJM, van Riel PLCM, van de Putte LBA. Bone mass in patients with rheumatoid arthritis. Ann Rheum Dis 1992;51:826-32.
19. Jowell PS, Epstein S, Fallon MD, Reinhardt TA, Ismail F. 1,25 Dihydroxyvitamin D3 modulates glucocorticoid-induced alteration in serum bone gla-protein and bone histomorphometry. Endocrinology 1987; 120:531-6.
20. Nielsen HK, Brixen K, Kassem M, Mosekilde L. Acute effects of 1,25 dihydroxyvitamin D3 plus prednisone on serum osteocalcin in normal individuals. J Bone Miner Res 1991;6:435-41.
21. Garnero P, Grimaux M, Demiaux B, Preaudat C, Seguin P, Delmas PD. Measurement of serum osteocalcin with a human specific two-site immunoradiometric assay. J Bone Miner Res 1992;7:1389-98.
22. Risteli J, Melkko J, Niemi S, Risteli L. Use of a marker of collagen formation in osteoporosis studies. Calcif Tissue Int 1991;49(suppl.):24-5.
23. Risteli J, Elomma I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type 1 collagen: a new serum marker of bone collagen degradation. Clin Chem 1993;39:635-40.
24. Gerrits MI, Thijssen JHH, van Rijn HJM. Determination of the bone resorption markers pyridinoline and deoxypyridinoline in urine, with special attention to retaining their stability. Clin Chem 1995;41:571-4.
25. Seibel MJ, Robins SP, Bilezikian JP. Urinary crosslinks of collagen. Trends Endocrinol Metab 1992;3:263-70.
26. Godschalk M, Downs R. Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Miner Res 1988;3:113-5.
27. Lems WF, Jacobs JWG, van Rijn HJM, Bijlsma JWJ. Changes in calcium and bone metabolism during treatment with low dose prednisone in young, healthy, male volunteers. Clin Rheumatol 1995;14:420-4.
28. Oikarinen A, Autio P, Vuori J, Vaananen K, Risteli L, Kiistala U et al. Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type 1 procollagen and aminoterminal propeptide of type 3 procollagen. Br J Dermatol 1992;126:172-8.
29. Gennari C, Inbimbo B, Montagnani M, Bernini M, Nardi P, Avioli LV. Effects of prednisone and deflazacort on mineral metabolism and parathyroid activity in humans. Calcif Tissue Int 1984;36:245-52.
30. Prummel MF, Wiersinga WM, Lips P, Sanders GTB, Sauerwein HP. The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab 1991;72:382-6.
31. Delmas PD. Biochemical markers of bone turnover. J Bone Miner Res 1993;8:S549-55.
32. Lems WF, van den Brink HR, Gerrits MI, van Rijn HJM, Bijlsma JWJ. Effect of hormonal replacement therapy on osteocalcin and markers of collagen type 1 turnover in postmenopausal patients with rheumatoid arthritis. Ann Rheum Dis 1993;52:335-6.
33. Eyre D. New markers of bone resorption. J Clin Endocrinol Metab 1992;74:470-1.
34. Pyridinium crosslinks as markers of bone resorption. [Editorial] Lancet 1992;340:278-9.
35. Colwell A, Russell RGG, Eastell R. Factors affecting the assay of urinary 3-hydroxypyridinium crosslinks of collagen as markers of bone resorption. Eur J Clin Invest 1993;23:341-9.
36. Emkey RD, Lindsay R, Lyssy J, Weisberg JS, Dempster DW, Shen V. The systemic effect of intra-articular administration of corticosteroid on markers of bone formation and bone resorption in patients with rheumatoid arthritis. Arthritis Rheum 1996;36:277-82.
37. Zerwekh, Sakhee K, Pak CYC. Short-term 1,25 dihydroxyvitamin D administration raises serum osteocalcin in patients with postmenopausal osteoporosis. J Clin Endocrin Metab 1985;60:615-7.
38. Morrison NA, Shine J, Fragonas JC, Verkest V, McEnemy L, Eisman JA. 1,25 Dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 1989;246:1158-61.
39. Bijlsma JWJ, Van Everdingen AA, Jacobs JWG. Corticosteroids in rheumatoid arthritis. Clin Immunother 1995;3:271-86.
40. Saag KG, Koehnke RN, Caldwell JR et al. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious advents. Am J Med 1994;96:115-23.
41. Gough AKS, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-7.
42. Kirwan JR and the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995;333:142-6.
43. Reid IR, Ibbertson HK. Calcium supplements in the prevention of steroid induced osteoporosis. Am J Clin Nutr 1986;44:287-90.
44. Bijlsma JWJ, Raymakers JA, Mosch C, Hoekstra A, Derksen RWHM, Baart de la Faille H et al. Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia. Clin Exp Rheumatol 1988;6:113-9.
45. Dyckman TR, Haralson KM, Gluck OS et al. Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1984;27:1336-43.
46. Adachi JD, Bensen WG, Bianchi F, Cividino A, Pillersdorf S, Sebaldt RJ et al. Vitamin D and calcium in the prevention of corticosteroid bone loss: what is the evidence? J Rheumatol 1996;23:963-4.
47. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N et al. Prevention of corticosteroid osteoporosis. N Engl J Med 1993;328:1747-52.
48. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med 1996;125:961-8.
49. Meunier PJ. Is steroid-induced osteoporosis preventable? N Engl J Med 1993;328:1781-2.